MATERIALS AND METHODS

Synthesis of the Compounds:
Column chromatography was performed with silica gel (230~400 mesh) purchased from Fisher Scientific and Sorbtech.
1 H NMR (300 MHz), 13 C NMR (75 MHz) and 31 P NMR (121 MHz) were recorded with Varian Mercury 300.
6-Chloro-7-deaza-7-(2-hydroxyethyl)-N(2)-pivaloyl-3',5'-di-O-p-toluoyl-2'-deoxyguanosine 6
OsO 4 (4% in water, 1.5 mL, 0.02 eq) was added to a mixture of starting material 5 containing an allyl group attached to the 7-deaza purine analog (7.7 g) and N-methylmorpholine oxide (1.68 g, 1.2 eq) in acetone (390 mL) and water (65 mL). The mixture was stirred at room temperature (rt) for 24 hours. The mixture was then diluted with H 2 O and extracted with CH 2 Cl 2 . The product was recovered following silica gel column chromatography (hexane:ethyl acetate=1:1 to ethyl acetate 100%) to give the diol as a white solid. This was dissolved in THF/H 2 O (300 mL/150 mL) and treated with NaIO 4 with stirring (30 min). The mixture was further diluted with water and extracted with CH 2 Cl 2 . Product was recovered following silica gel column chromatography (dichloromethane:hexane =1:1 to dichloromethane:hexane:ethyl acetate=3:3:2) gave an aldehyde as a white solid; this was not further characterized, but instead immediately dissolved in MeOH/THF (150 mL:150 mL) and treated with NaBH 4 . The mixture was stirred at rt for 20 min (reaction complete). The mixture was mixed with water and extracted with CH 2 Cl 2 . Product 6 was recovered following silica gel column (dichloromethane:hexane:ethyl acetate=1:1:2) as a white solid (4.3 g, 6.6 mmol, 55% for 3 steps from the allyl compound) of white solid. 69, 166.36, 166.31, 152.86, 152.06, 151.46, 144.48, 144.25, 130.09, 129.86, 129.41, 127.19, 126.90, 124.16, 113.67, 113.40, 84.70, 82.60, 75.34, 64.32, 62.68, 40.43, 37.78, 29.41, 27.63, 21.85 
6-Chloro-7-deaza-7-(2-methanesulfonyloxy ethyl)-N(2)-pivaloyl-3',5'-di-O-p-toluoyl-2'-deoxyguanosine 7
To a solution of 6 (4.3 g) in CH 2 Cl 2 (~100 mL) and pyridine (7 mL) was added methanesulfonyl chloride (3.5 mL). The mixture was stirred at rt for 2 hours. 68, 166.27, 152.80, 151.86, 151.70, 144.49, 144.34, 130.08, 129.81, 129.46, 129.42, 127.17, 126.88, 124.85, 113.30, 110.92, 84.81, 82.66, 75.27, 69.07, 67.29, 64.24, 40.45, 37.81, 37.75, 27.61, 26.21, 21.84, 21.79 166.59, 166.20, 145.38, 144.47, 144.41, 141.48, 129.97, 129.83, 129.44, 129.40, 127.08, 117.59, 113.65, 99.29, 85.14, 81.89, 75.20, 70.20, 64.36, 63.68, 40.39, 37.42, 37.17, 27.24, 27.08, 21.82 To a solution of 8 (2.6 g, 3.6 mmol) in DMF (~150 mL) was added potassium tert-butoxide (605 mg, 5.4 mmol). The mixture was stirred at rt for 8 hours. The mixture was mixed with water and extracted with ethyl acetate. The organic layer was evaporated and the intermediate recovered following silica gel chromatography, dichloromethane:ethyl acetate=5:1 to give a white solid (1.3 g, 2.1 mmol, 58%). This material contained some impurities by NMR. Therefore, it was dissolved in saturated NH 3 in MeOH (50 mL) and stirred at rt for 24 hours. Volatiles were removed by rotary evaporation and the product 9 was recovered following silica gel chromatography (ethyl acetate to ethyl acetate:MeOH=10:1) to give a white solid, mp; 58~59 °C, 490 mg, 1.25 mmol, 35% 1 H NMR (300 MHz, CDCl 3 ) δ 9.1 (br s, 1H), 8.07 (s, 1H), 6.79 (s, 1H), 6.25 (dd, 1H, J = 9.0 Hz, 5.7 Hz), 6.00 (br s, 1H), 4.79 (d, 1H, J = 5.1 Hz,) 3.8~4.5 (m, 6H), 2.8~3.0 (m, 3H), 2.3~2.4 (m, 1H), 1.30 (s, 9H).
13 C NMR (75 MHz, CDCl 3 ) δ 176. 46, 162.66, 151.27, 150.30, 121.01, 113.18, 103.19, 86.61, 88.25, 77.29, 73.24, 63.61, 40.66, 40.35, 20.06, 27.61 To a mixture of 9 (500 mg, 1.28 mmol) and imidazole (436 mg, 6.4 mmol) in CH 2 Cl 2 (15 mL) was added tert-butyldimethylsilaneCl (578 mg, 3.83 mmol) and the mixture was stirred at rt for 6 h. Extended incubation was found to give tri-tert-butyldimethylsilane product. The product was mixed with water and extracted with CH 2 Cl 2 . The organic layer was dried and evaporated, and the di-tertbutyldimethylsilane product was purified by silica gel chromatography. This was dissolved in CH 2 Cl 2 (15 mL) and pyridine (0.6 mL) and treated with acetic anhydride (0.4 mL). The mixture was stirred at rt for 30 min, treated with dilute HCl, and then extracted with CH 2 Cl 2 . The organic layer was dried and evaporated, and product 11 was purified by silica gel chromatography (ethyl acetate:hexane=1:1) to give a white solid, mp; 92~93 °C, 466 mg, 0.70 mmol, 55%. 54, 168.00, 154.28, 153.07, 151.05, 120.43, 112.88, 104.63, 87.56, 83.31, 79.48, 72.27, 63.18, 41.41, 40.33, 27.76, 27.29, 26.14, 26.00, 25.24, 18.60, 18.22, -4.42, -4.55, -5.19, -5.30 A mixture of 11 (420 mg, 0.634 mmol), TBAF (2.5 mL, 1M in THF) and acetic acid (0.25 mL) in THF (20 mL) was stirred at 55 °C for 6 hours. The mixture was mixed with water and THF was removed by rotary evaporation. The residue was extracted with CH 2 Cl 2 and the diol was purified by silica gel chromatography (ethyl acetate:MeOH=10:1) as a white solid. This was dissolved without further characterization in CH 2 Cl 2 (10 mL) containing 4-methylmorpholine (0.2 mL) and treated with dimethoxytrityl chloride (230 mg). The mixture was stirred at rt for 20 min and poured into water and extracted with CH 2 Cl 2 . The organic layer was dried and evaporated, and the product 12 was purified by silica gel chromatography (ethyl acetate 93, 168.27, 158.88, 154.05, 153.24, 151.11, 144.92, 136.11, 136.03, 130.42, 128.57, 127.99, 127.11, 120.80, 113.39, 112.75, 104.57, 86.87, 86.08, 83.31, 79.58, 72.98, 64.46, 55.40, 40.99, 40.35, 27.70, 27.14, 24.92 Mass spectrum of compound 12
2-(2-Deoxy-5-O-(4,4'-dimethoxytrityl)-3-[(2-cyanoethyl)-N,N-diisopropylphosphoramidite] -β-Dribofuranosyl)-4-pivaloylamino-2,6,8,9-tetrahydro-6-N-(acetyl)-7-oxa-2,3,5,6-tetraazabenz[cd]azulene 13
To a mixture of 12 (365 mg, 0.496 mmol) and 4-methylmorpholine (0.2 mL) was added 2-cyanoethyl N,N-diisopropylchlorophosphoramidite (0.2 mL). The mixture was stirred at rt for 30 min and poured into water and extracted with CH 2 Cl 2 . The organic layer was dried and evaporated, and the product 13 purified by chromatography on a neutral silica column (ethyl acetate Mass spectrum of compound 13
Sanger Sequencing of the PCR Products generated with 3H-and 4H-containing primers Wild type DNA template was respectively amplified by standard primers, 3H-or 4H-containing primers (1 µM of each primer) in 1x AmpliTaq Gold reaction buffer (15 mM Tris-HCl, 50 mM KCl, pH 8.3 at 25 °C), MgCl 2 (3 mM), dNTPs (each 0.2 mM), and 2.5 units of Hot Start AmpliTaq Gold DNA polymerase (5 U/µL, ABI) in a total volume of 25 µL reaction. The following PCR conditions were used: one cycle of 95 °C for 10 min; followed by 35 cycles of (95 °C for 10 s, 50 °C for 30 s, 72 °C for 30 s); and finally 72 °C for 5 min. Upon the completion of the PCR, samples (10 µL) were taken from each PCR mixture, mixed with 6x agarose loading dye (2 µL, Promega), and analyzed by 3% agarose gel electrophoresis. PCR products (2 µL) were cloned into the pCR TM 4-TOPO ® vector using TOPO TA Cloning Kit (Invitrogen, Carlsbad, CA) and transformed the recombinant vector into One Shot ® TOP10 competent cells following manufacturer's instruction. Blue-white screening gave 16 to 32 colonies that were submitted for Sanger sequencing (BioBasic, Canada). The sequencing results and Figure are shown in Supplementary Table S1 and Figure S1 . Figure S1 . PCR assays using standard primers or biversal analogous containing primers (3dH-and 4dH-primer). Lanes 1, 4, and 7: 3 x 10 6 copies of input target DNA. Lanes 2, 5, and 8: 3 x 10 4 copies of input target DNA. Lanes 3, 6, and 9: no target controls (NTC). Amplicons from PCR assays were resolved on agarose gel (2.5%) and stained with ethidium bromide. M 25 indicates 25 bp DNA ladder. Table S1 . Results shown that over 95% of H is converted to A through dTTP incorporation. Figure S3a . Real-time PCR curves show the amplification of standard primer, 4H-, and 4I-containing primers targeting on wild type consensus (WT) or divergent (Div4) targets. Amplification efficiency was monitored based on the fluorescence of EvaGreen dye at two target concentrations, 3 x 10 6 copies (Hi) or 3 x 10 4 copies (Lo) per assay. NTC indicates no template control. All curves represent three replicates. Table S2 . Biversal pyrimidine (P) containing probes and targets used in ligation assays: 
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